Forty51 closes first fund totaling 43 million US dollars A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million…annett07.19.2022
Basel Area achieves milestone with settling of LifeMine Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the…martin07.06.2022
Space Pharmaceuticals establishes presence in Basel Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its…martin07.01.2022
What’s fueling Basel Area’s advanced manufacturing ecosystem The Covid-19 pandemic continues to have an unmistakable effect on the pharmaceutical industry and its…annelise06.29.2022
ti&m opens branch in Basel ti&m now has an office in Basel. With this action, the company specializing in digitization,…martin06.16.2022
Economic promotion agency creates 55 new jobs in Jura The economic promotion agency of the canton of Jura supported a total of 26 companies…martin06.10.2022
Investors top up capital of BioVersys BioVersys has raised 24.2 million Swiss francs in a series C funding round. The Basel-based…martin06.09.2022
EvokAI to acquire Advancience EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced…martin05.30.2022
BeiGene opens European headquarters in Basel BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative…martin05.19.2022
Engimmune Therapeutics banks 15.5 million Swiss francs Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for…martin05.03.2022